<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>How To Stop Premature Ejaculation &#187; European Phase</title>
	<atom:link href="http://www.controlyourorgasms.com/wp/tag/european-phase/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.controlyourorgasms.com/wp</link>
	<description>Discover how to stop premature ejaculation and how to last longer in bed.</description>
	<lastBuildDate>Wed, 01 Feb 2012 13:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Small caps round-up: Ten Alps/BT, Monitise, Plethora&#8230; &#8211; ShareCast</title>
		<link>http://www.controlyourorgasms.com/wp/3395/small-caps-round-up-ten-alpsbt-monitise-plethora-sharecast/</link>
		<comments>http://www.controlyourorgasms.com/wp/3395/small-caps-round-up-ten-alpsbt-monitise-plethora-sharecast/#comments</comments>
		<pubDate>Mon, 08 Dec 2008 14:33:16 +0000</pubDate>
		<dc:creator>premature ejaculation - Google News</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Alps]]></category>
		<category><![CDATA[Bt Uk]]></category>
		<category><![CDATA[Double Blind Placebo]]></category>
		<category><![CDATA[European Phase]]></category>
		<category><![CDATA[Monitise]]></category>
		<category><![CDATA[Nbsp]]></category>
		<category><![CDATA[Phase Iii]]></category>
		<category><![CDATA[Plethora Solutions]]></category>
		<category><![CDATA[Small Caps]]></category>
		<category><![CDATA[Treatment Of Premature Ejaculation]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="valign=top" cellpadding="2" cellspacing="7"><tr><td valign="top" class="j"><font><br /><div style="0.8em;"><img alt="" height="1" width="1"></div><div class="lh"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/9-0&#38;fd=R&#38;url=http://www.sharecast.com/cgi-bin/sharecast/story.cgi%3Fstory_id%3D2498932&#38;cid=1278665662&#38;ei=vKM9SZnXD4LCgAO3i6WfCQ&#38;usg=AFQjCNG9hoJe6al8QSS-e9AgPk8nLZ7H6w">Small caps round-up: Ten Alps/BT, Monitise, Plethora...</a><br /><font size="-1"><font color="#6f6f6f">ShareCast,&#160;UK&#160;-</font> 8 hours ago</font><br /><font size="-1">Plethora Solutions&#39;s final analysis of its European Phase III double-blind placebo controlled study  of PSD502 for the treatment of <b>premature ejaculation</b> met <b>...</b></font></div></font></td></tr></table>]]></description>
			<content:encoded><![CDATA[<table border=0 width= valign=top cellpadding=2 cellspacing=7><tr><td valign=top class=j><font ><br><div ><img alt="" height="1" width="1"></div><div class=lh><a href="http://news.google.com/news/url?sa=T&ct=us/9-0&fd=R&url=http://www.sharecast.com/cgi-bin/sharecast/story.cgi%3Fstory_id%3D2498932&cid=1278665662&ei=vKM9SZnXD4LCgAO3i6WfCQ&usg=AFQjCNG9hoJe6al8QSS-e9AgPk8nLZ7H6w">Small caps round-up: Ten Alps/BT, Monitise, Plethora...</a><br><font size=-1><font color=#6f6f6f>ShareCast,&nbsp;UK&nbsp;-</font> <nobr>8 hours ago</nobr></font><br><font size=-1>Plethora Solutions&#39;s final analysis of its European Phase III double-blind placebo controlled study  of PSD502 for the treatment of <b>premature ejaculation</b> met <b>...</b></font></div></font></td></tr></table>]]></content:encoded>
			<wfw:commentRss>http://www.controlyourorgasms.com/wp/3395/small-caps-round-up-ten-alpsbt-monitise-plethora-sharecast/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Sciele Pharma and Plethora Solutions Announce Positive Phase III &#8230; &#8211; PR-Inside.com (Pressemitteilung)</title>
		<link>http://www.controlyourorgasms.com/wp/377/sciele-pharma-and-plethora-solutions-announce-positive-phase-iii-pr-insidecom-pressemitteilung/</link>
		<comments>http://www.controlyourorgasms.com/wp/377/sciele-pharma-and-plethora-solutions-announce-positive-phase-iii-pr-insidecom-pressemitteilung/#comments</comments>
		<pubDate>Mon, 10 Nov 2008 01:18:22 +0000</pubDate>
		<dc:creator>premature ejaculation - Google News</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Austria]]></category>
		<category><![CDATA[Double Blind Placebo]]></category>
		<category><![CDATA[Endpoints]]></category>
		<category><![CDATA[European Phase]]></category>
		<category><![CDATA[Nbsp]]></category>
		<category><![CDATA[Phase Iii]]></category>
		<category><![CDATA[Plethora Solutions]]></category>
		<category><![CDATA[Sciele Pharma]]></category>
		<category><![CDATA[Treatment Of Premature Ejaculation]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="valign=top" cellpadding="2" cellspacing="7"><tr><td valign="top" class="j"><font><br /><div style="0.8em;"><img alt="" height="1" width="1"></div><div class="lh"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/9-0&#38;fd=R&#38;url=http://www.pr-inside.com/sciele-pharma-and-plethora-solutions-announce-r905714.htm&#38;cid=0&#38;ei=Wds5SaDiIpDKlQSYk7SVCQ&#38;usg=AFQjCNG61weM3zqw8QpQ2kp-8YoTTV7BEg">Sciele Pharma and Plethora Solutions Announce Positive Phase III <b>...</b></a><br /><font size="-1"><font color="#6f6f6f">PR-Inside.com (Pressemitteilung),&#160;Austria&#160;-</font> Nov 9, 2008</font><br /><font size="-1">European Phase III double-blind placebo-controlled study of PSD502 for the treatment of <b>premature ejaculation</b> (&#39;PE&#39;) has met its three co-primary endpoints <b>...</b></font></div></font></td></tr></table>]]></description>
			<content:encoded><![CDATA[<table border=0 width= valign=top cellpadding=2 cellspacing=7><tr><td valign=top class=j><font ><br><div ><img alt="" height="1" width="1"></div><div class=lh><a href="http://news.google.com/news/url?sa=T&ct=us/9-0&fd=R&url=http://www.pr-inside.com/sciele-pharma-and-plethora-solutions-announce-r905714.htm&cid=0&ei=Wds5SaDiIpDKlQSYk7SVCQ&usg=AFQjCNG61weM3zqw8QpQ2kp-8YoTTV7BEg">Sciele Pharma and Plethora Solutions Announce Positive Phase III <b>...</b></a><br><font size=-1><font color=#6f6f6f>PR-Inside.com (Pressemitteilung),&nbsp;Austria&nbsp;-</font> <nobr>Nov 9, 2008</nobr></font><br><font size=-1>European Phase III double-blind placebo-controlled study of PSD502 for the treatment of <b>premature ejaculation</b> (&#39;PE&#39;) has met its three co-primary endpoints <b>...</b></font></div></font></td></tr></table>]]></content:encoded>
			<wfw:commentRss>http://www.controlyourorgasms.com/wp/377/sciele-pharma-and-plethora-solutions-announce-positive-phase-iii-pr-insidecom-pressemitteilung/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Plethora&#039;s European Phase III premature ejaculation study meets &#8230; &#8211; Pharmaceutical Business Review</title>
		<link>http://www.controlyourorgasms.com/wp/2939/plethoras-european-phase-iii-premature-ejaculation-study-meets-pharmaceutical-business-review/</link>
		<comments>http://www.controlyourorgasms.com/wp/2939/plethoras-european-phase-iii-premature-ejaculation-study-meets-pharmaceutical-business-review/#comments</comments>
		<pubDate>Sat, 08 Nov 2008 02:53:56 +0000</pubDate>
		<dc:creator>premature ejaculation - Google News</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Business Review]]></category>
		<category><![CDATA[Domain]]></category>
		<category><![CDATA[European Phase]]></category>
		<category><![CDATA[Lt]]></category>
		<category><![CDATA[Pharmaceutical Business]]></category>
		<category><![CDATA[Phase Iii]]></category>
		<category><![CDATA[Placebo]]></category>
		<category><![CDATA[Plethora]]></category>
		<category><![CDATA[Premature Ejaculation Study]]></category>
		<category><![CDATA[Sexual Satisfaction]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="valign=top" cellpadding="2" cellspacing="7"><tr><td valign="top" class="j"><font><br /><div style="0.8em;"><img alt="" height="1" width="1"></div><div class="lh"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/2-0&#38;fd=R&#38;url=http://www.pharmaceutical-business-review.com/article_news.asp%3Fguid%3D639E5058-2038-4972-85AE-1009ED86F08F&#38;cid=0&#38;ei=6Yw4SZzqCJPEgAPf052DDw&#38;usg=AFQjCNGSFLcVQb22Iv6R4mYrSaIG6nnvmg">Plethora&#39;s European Phase III <b>premature ejaculation</b> study meets <b>...</b></a><br /><font size="-1"><font color="#6f6f6f">Pharmaceutical Business Review&#160;-</font> Nov 7, 2008</font><br /><font size="-1"><b>...</b> (p&#60;0.0001) and a six point difference between PSD502 and placebo in the index of <b>premature ejaculation</b> (IPE)  domain for sexual satisfaction (p&#60;0.0001), <b>...</b></font></div></font></td></tr></table>]]></description>
			<content:encoded><![CDATA[<table border=0 width= valign=top cellpadding=2 cellspacing=7><tr><td valign=top class=j><font ><br><div ><img alt="" height="1" width="1"></div><div class=lh><a href="http://news.google.com/news/url?sa=T&ct=us/2-0&fd=R&url=http://www.pharmaceutical-business-review.com/article_news.asp%3Fguid%3D639E5058-2038-4972-85AE-1009ED86F08F&cid=0&ei=6Yw4SZzqCJPEgAPf052DDw&usg=AFQjCNGSFLcVQb22Iv6R4mYrSaIG6nnvmg">Plethora&#39;s European Phase III <b>premature ejaculation</b> study meets <b>...</b></a><br><font size=-1><font color=#6f6f6f>Pharmaceutical Business Review&nbsp;-</font> <nobr>Nov 7, 2008</nobr></font><br><font size=-1><b>...</b> (p&lt;0.0001) and a six point difference between PSD502 and placebo in the index of <b>premature ejaculation</b> (IPE)  domain for sexual satisfaction (p&lt;0.0001), <b>...</b></font></div></font></td></tr></table>]]></content:encoded>
			<wfw:commentRss>http://www.controlyourorgasms.com/wp/2939/plethoras-european-phase-iii-premature-ejaculation-study-meets-pharmaceutical-business-review/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>London pre-open: Slim loss to start &#8211; ShareCast</title>
		<link>http://www.controlyourorgasms.com/wp/144/london-pre-open-slim-loss-to-start-sharecast/</link>
		<comments>http://www.controlyourorgasms.com/wp/144/london-pre-open-slim-loss-to-start-sharecast/#comments</comments>
		<pubDate>Fri, 07 Nov 2008 07:46:05 +0000</pubDate>
		<dc:creator>premature ejaculation - Google News</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[European Phase]]></category>
		<category><![CDATA[London]]></category>
		<category><![CDATA[Nbsp]]></category>
		<category><![CDATA[Phase Iii]]></category>
		<category><![CDATA[Plethora Solutions]]></category>
		<category><![CDATA[Premature Ejaculation]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="valign=top" cellpadding="2" cellspacing="7"><tr><td valign="top" class="j"><font><br /><div style="0.8em;"><img alt="" height="1" width="1"></div><div class="lh"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/9-0&#38;fd=R&#38;url=http://www.sharecast.com/cgi-bin/sharecast/story.cgi%3Fstory_id%3D2443234&#38;cid=1267868405&#38;ei=0_oTSeGBKIaqNp21qOwD&#38;usg=AFQjCNHnEU_LQ1A02sDDJ0pTVhUFDIonog">London pre-open: Slim loss to start</a><br /><font size="-1"><font color="#6f6f6f">ShareCast,&#160;UK&#160;-</font> 36 minutes ago</font><br /><font size="-1">Urology drug specialsit  Plethora Solutions says its key <b>premature ejaculation</b> drug has met all of its goals in a European phase III trial. <b>...</b></font></div></font></td></tr></table>]]></description>
			<content:encoded><![CDATA[<table border=0 width= valign=top cellpadding=2 cellspacing=7><tr><td valign=top class=j><font ><br><div ><img alt="" height="1" width="1"></div><div class=lh><a href="http://news.google.com/news/url?sa=T&ct=us/9-0&fd=R&url=http://www.sharecast.com/cgi-bin/sharecast/story.cgi%3Fstory_id%3D2443234&cid=1267868405&ei=0_oTSeGBKIaqNp21qOwD&usg=AFQjCNHnEU_LQ1A02sDDJ0pTVhUFDIonog">London pre-open: Slim loss to start</a><br><font size=-1><font color=#6f6f6f>ShareCast,&nbsp;UK&nbsp;-</font> <nobr>36 minutes ago</nobr></font><br><font size=-1>Urology drug specialsit  Plethora Solutions says its key <b>premature ejaculation</b> drug has met all of its goals in a European phase III trial. <b>...</b></font></div></font></td></tr></table>]]></content:encoded>
			<wfw:commentRss>http://www.controlyourorgasms.com/wp/144/london-pre-open-slim-loss-to-start-sharecast/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sciele Pharma and Plethora Solutions Announce Positive Phase III &#8230; &#8211; Business Wire (press release)</title>
		<link>http://www.controlyourorgasms.com/wp/2943/sciele-pharma-and-plethora-solutions-announce-positive-phase-iii-business-wire-press-release/</link>
		<comments>http://www.controlyourorgasms.com/wp/2943/sciele-pharma-and-plethora-solutions-announce-positive-phase-iii-business-wire-press-release/#comments</comments>
		<pubDate>Fri, 07 Nov 2008 13:02:54 +0000</pubDate>
		<dc:creator>premature ejaculation - Google News</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Business Wire]]></category>
		<category><![CDATA[European Phase]]></category>
		<category><![CDATA[Investors Uk]]></category>
		<category><![CDATA[Nbsp]]></category>
		<category><![CDATA[News Articles]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Pharmaceutical Treatments]]></category>
		<category><![CDATA[Phase Iii]]></category>
		<category><![CDATA[Plethora Solutions]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Proactive]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="valign=top" cellpadding="2" cellspacing="7"><tr><td width="80" align="center" valign="top"><font><a href="http://news.google.com/news/url?sa=T&#38;ct=us/5i-0&#38;fd=R&#38;url=http://www.businesswire.com/news/google/20081107005060/en&#38;cid=1267865549&#38;ei=aM83SazqAYb2gAPbm-GLDw&#38;usg=AFQjCNGLmvX0i3R6KNcKdsTN1MHu9H4u5g"><img src="http://news.google.com/news?imgefp=XU8lyJJjozQJ&#38;imgurl=mms.businesswire.com/bwapps/mediaserver/ViewMedia%3Fmgid%3D78138%26vid%3D2" width="80" height="44" alt="" border="1"><br /><font size="-2">Business Wire (press release)</font></a></font></td><td valign="top" class="j"><font><br /><div style="0.8em;"><img alt="" height="1" width="1"></div><div class="lh"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/5-0&#38;fd=R&#38;url=http://www.businesswire.com/news/google/20081107005060/en&#38;cid=1267865549&#38;ei=aM83SazqAYb2gAPbm-GLDw&#38;usg=AFQjCNGLmvX0i3R6KNcKdsTN1MHu9H4u5g">Sciele Pharma and Plethora Solutions Announce Positive Phase III <b>...</b></a><br /><font size="-1"><font color="#6f6f6f">Business Wire (press release),&#160;CA&#160;-</font> Nov 7, 2008</font><br /><font size="-1">There are currently no approved pharmaceutical treatments for <b>premature ejaculation</b>. PSD502 is applied locally &#34;on demand&#34; and is effective within five <b>...</b></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/5-1&#38;fd=R&#38;url=http://proactiveinvestors.co.uk/companies/news/3378/plethora-reports-positive-outcomes-of-european-phase-iii-trials-of-premature-ejaculation-treatment--3378.html&#38;cid=1267865549&#38;ei=aM83SazqAYb2gAPbm-GLDw&#38;usg=AFQjCNG9Zl1dq0Y6x1wYGhpIKFdw2NXbMg">Plethora: Plethora reports positive outcomes of European Phase III <b>...</b></a> <font size="-1" color="#6f6f6f">Proactive Investors UK</font></font><br /><font size="-1"><a class="p" href="http://news.google.com/news?ie=UTF-8&#38;oe=utf-8&#38;rls=org.mozilla:en-US:official&#38;client=firefox-a&#38;tab=wn&#38;ncl=1267865549&#38;hl=en">all 14 news articles</a></font></div></font></td></tr></table>]]></description>
			<content:encoded><![CDATA[<table border=0 width= valign=top cellpadding=2 cellspacing=7><tr><td width=80 align=center valign=top><font ><a  href="http://news.google.com/news/url?sa=T&ct=us/5i-0&fd=R&url=http://www.businesswire.com/news/google/20081107005060/en&cid=1267865549&ei=aM83SazqAYb2gAPbm-GLDw&usg=AFQjCNGLmvX0i3R6KNcKdsTN1MHu9H4u5g"><img src=http://news.google.com/news?imgefp=XU8lyJJjozQJ&imgurl=mms.businesswire.com/bwapps/mediaserver/ViewMedia%3Fmgid%3D78138%26vid%3D2 width=80 height=44 alt="" border=1><br><font size=-2>Business Wire (press release)</font></a></font></td><td valign=top class=j><font ><br><div ><img alt="" height="1" width="1"></div><div class=lh><a href="http://news.google.com/news/url?sa=T&ct=us/5-0&fd=R&url=http://www.businesswire.com/news/google/20081107005060/en&cid=1267865549&ei=aM83SazqAYb2gAPbm-GLDw&usg=AFQjCNGLmvX0i3R6KNcKdsTN1MHu9H4u5g">Sciele Pharma and Plethora Solutions Announce Positive Phase III <b>...</b></a><br><font size=-1><font color=#6f6f6f>Business Wire (press release),&nbsp;CA&nbsp;-</font> <nobr>Nov 7, 2008</nobr></font><br><font size=-1>There are currently no approved pharmaceutical treatments for <b>premature ejaculation</b>. PSD502 is applied locally &quot;on demand&quot; and is effective within five <b>...</b></font><br><font size=-1><a href="http://news.google.com/news/url?sa=T&ct=us/5-1&fd=R&url=http://proactiveinvestors.co.uk/companies/news/3378/plethora-reports-positive-outcomes-of-european-phase-iii-trials-of-premature-ejaculation-treatment--3378.html&cid=1267865549&ei=aM83SazqAYb2gAPbm-GLDw&usg=AFQjCNG9Zl1dq0Y6x1wYGhpIKFdw2NXbMg">Plethora: Plethora reports positive outcomes of European Phase III <b>...</b></a> <font size=-1 color=#6f6f6f><nobr>Proactive Investors UK</nobr></font></font><br><font class=p size=-1><a class=p href=http://news.google.com/news?ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&tab=wn&ncl=1267865549&hl=en><nobr>all 14 news articles</nobr></a></font></div></font></td></tr></table>]]></content:encoded>
			<wfw:commentRss>http://www.controlyourorgasms.com/wp/2943/sciele-pharma-and-plethora-solutions-announce-positive-phase-iii-business-wire-press-release/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Friday&#039;s news and tips &#8211; Investors Chronicle</title>
		<link>http://www.controlyourorgasms.com/wp/152/fridays-news-and-tips-investors-chronicle/</link>
		<comments>http://www.controlyourorgasms.com/wp/152/fridays-news-and-tips-investors-chronicle/#comments</comments>
		<pubDate>Fri, 07 Nov 2008 09:21:10 +0000</pubDate>
		<dc:creator>premature ejaculation - Google News</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Drug Specialist]]></category>
		<category><![CDATA[European Phase]]></category>
		<category><![CDATA[Investors Chronicle]]></category>
		<category><![CDATA[Nbsp]]></category>
		<category><![CDATA[News Uk]]></category>
		<category><![CDATA[Phase Iii]]></category>
		<category><![CDATA[Plethora Solutions]]></category>
		<category><![CDATA[Premature Ejaculation]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="valign=top" cellpadding="2" cellspacing="7"><tr><td valign="top" class="j"><font><br /><div style="0.8em;"><img alt="" height="1" width="1"></div><div class="lh"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/9-0&#38;fd=R&#38;url=http://www.investorschronicle.co.uk/Companies/ByEvent/Fundraisings/Inbrief/article/20081107/ef9e8830-aca5-11dd-a431-00144f2af8e8/Fridays-news-and-tips.jsp&#38;cid=0&#38;ei=2qYXSc-WBoP4lQSVxcn2Ag&#38;usg=AFQjCNG_3qcmcIhOVzd3xgQhieREHmsgLw">Friday&#39;s news and tips</a><br /><font size="-1"><font color="#6f6f6f">Investors Chronicle,&#160;UK&#160;-</font> Nov 7, 2008</font><br /><font size="-1">Urology drug specialist  Plethora Solutions says its key <b>premature ejaculation</b> drug has met all of its goals in a European phase III trial. <b>...</b></font></div></font></td></tr></table>]]></description>
			<content:encoded><![CDATA[<table border=0 width= valign=top cellpadding=2 cellspacing=7><tr><td valign=top class=j><font ><br><div ><img alt="" height="1" width="1"></div><div class=lh><a href="http://news.google.com/news/url?sa=T&ct=us/9-0&fd=R&url=http://www.investorschronicle.co.uk/Companies/ByEvent/Fundraisings/Inbrief/article/20081107/ef9e8830-aca5-11dd-a431-00144f2af8e8/Fridays-news-and-tips.jsp&cid=0&ei=2qYXSc-WBoP4lQSVxcn2Ag&usg=AFQjCNG_3qcmcIhOVzd3xgQhieREHmsgLw">Friday&#39;s news and tips</a><br><font size=-1><font color=#6f6f6f>Investors Chronicle,&nbsp;UK&nbsp;-</font> <nobr>Nov 7, 2008</nobr></font><br><font size=-1>Urology drug specialist  Plethora Solutions says its key <b>premature ejaculation</b> drug has met all of its goals in a European phase III trial. <b>...</b></font></div></font></td></tr></table>]]></content:encoded>
			<wfw:commentRss>http://www.controlyourorgasms.com/wp/152/fridays-news-and-tips-investors-chronicle/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Plethora premature ejaculation drug meets goals &#8211; Reuters UK</title>
		<link>http://www.controlyourorgasms.com/wp/135/plethora-premature-ejaculation-drug-meets-goals-reuters-uk/</link>
		<comments>http://www.controlyourorgasms.com/wp/135/plethora-premature-ejaculation-drug-meets-goals-reuters-uk/#comments</comments>
		<pubDate>Fri, 07 Nov 2008 07:08:12 +0000</pubDate>
		<dc:creator>premature ejaculation - Google News</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Business Wire]]></category>
		<category><![CDATA[European Phase]]></category>
		<category><![CDATA[Goals]]></category>
		<category><![CDATA[Investors Uk]]></category>
		<category><![CDATA[Met]]></category>
		<category><![CDATA[Nbsp]]></category>
		<category><![CDATA[News Articles]]></category>
		<category><![CDATA[Phase Iii]]></category>
		<category><![CDATA[Plethora Solutions]]></category>
		<category><![CDATA[Premature Ejaculation]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[Proactive]]></category>
		<category><![CDATA[Profile Research]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Sciele Pharma]]></category>
		<category><![CDATA[Target]]></category>
		<category><![CDATA[Uk News]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="valign=top" cellpadding="2" cellspacing="7"><tr><td valign="top" class="j"><font><br /><div style="0.8em;"><img alt="" height="1" width="1"></div><div class="lh"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/0-0&#38;fd=R&#38;url=http://uk.reuters.com/article/hotStocksNews/idUKWLB304520081107&#38;cid=1267865549&#38;ei=CHQ3SeQJhM6AA9aQuIUP&#38;usg=AFQjCNF_0CI7I2eXo8FloDWalLSdp5XzDw">Plethora <b>premature ejaculation</b> drug meets goals</a><br /><font size="-1"><font color="#6f6f6f">Reuters UK,&#160;UK&#160;-</font> Nov 6, 2008</font><br /><font size="-1">L: Quote, Profile,  Research) said on Friday its <b>premature ejaculation</b> drug has met all of its goals in a phase III trial. The company said PSD502, <b>...</b></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/0-1&#38;fd=R&#38;url=http://www.businesswire.com/news/google/20081107005060/en&#38;cid=1267865549&#38;ei=CHQ3SeQJhM6AA9aQuIUP&#38;usg=AFQjCNHrKfVtE4Kcm9iQg9qyxfa6fDv88A">Sciele Pharma and Plethora Solutions Announce Positive Phase III <b>...</b></a> <font size="-1" color="#6f6f6f">Business Wire (press release)</font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/0-2&#38;fd=R&#38;url=http://proactiveinvestors.co.uk/companies/news/3378/plethora-reports-positive-outcomes-of-european-phase-iii-trials-of-premature-ejaculation-treatment--3378.html&#38;cid=1267865549&#38;ei=CHQ3SeQJhM6AA9aQuIUP&#38;usg=AFQjCNHL0bBmTW-oPzzVlZkqlp7SB3a_2Q">Plethora: Plethora reports positive outcomes of European Phase III <b>...</b></a> <font size="-1" color="#6f6f6f">Proactive Investors UK</font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/0-3&#38;fd=R&#38;url=http://www.sharecast.com/cgi-bin/sharecast/story.cgi%3Fstory_id%3D2443166&#38;cid=1267865549&#38;ei=CHQ3SeQJhM6AA9aQuIUP&#38;usg=AFQjCNESNcJlQfboN0QSljbcvBL1yVv_NA">Plethora hits target in European trial</a> <font size="-1" color="#6f6f6f">ShareCast</font></font><br /><font size="-1"><a href="http://news.google.com/news/url?sa=T&#38;ct=us/0-4&#38;fd=R&#38;url=http://www.hemscott.com/news/static/tfn/item.do%3FnewsId%3D70338679474418&#38;cid=1267865549&#38;ei=CHQ3SeQJhM6AA9aQuIUP&#38;usg=AFQjCNGJO-dGzrdPy24kLdzY5vcHNRtD4w">Hemscott</a>&#160;- <a href="http://news.google.com/news/url?sa=T&#38;ct=us/0-5&#38;fd=R&#38;url=http://www.growthbusiness.co.uk/news/smallcap-spotlight/812022/eu-trial-cheers-plethora.thtml&#38;cid=1267865549&#38;ei=CHQ3SeQJhM6AA9aQuIUP&#38;usg=AFQjCNFj-rVYaFVaGnmeQ7tNXiiU49CnTA">GrowthBusiness.co.uk</a></font><br /><font size="-1"><a class="p" href="http://news.google.com/news?ie=UTF-8&#38;oe=utf-8&#38;rls=org.mozilla:en-US:official&#38;client=firefox-a&#38;tab=wn&#38;ncl=1267865549&#38;hl=en">all 14 news articles</a></font></div></font></td></tr></table>]]></description>
			<content:encoded><![CDATA[<table border=0 width= valign=top cellpadding=2 cellspacing=7><tr><td valign=top class=j><font ><br><div ><img alt="" height="1" width="1"></div><div class=lh><a href="http://news.google.com/news/url?sa=T&ct=us/0-0&fd=R&url=http://uk.reuters.com/article/hotStocksNews/idUKWLB304520081107&cid=1267865549&ei=CHQ3SeQJhM6AA9aQuIUP&usg=AFQjCNF_0CI7I2eXo8FloDWalLSdp5XzDw">Plethora <b>premature ejaculation</b> drug meets goals</a><br><font size=-1><font color=#6f6f6f>Reuters UK,&nbsp;UK&nbsp;-</font> <nobr>Nov 6, 2008</nobr></font><br><font size=-1>L: Quote, Profile,  Research) said on Friday its <b>premature ejaculation</b> drug has met all of its goals in a phase III trial. The company said PSD502, <b>...</b></font><br><font size=-1><a href="http://news.google.com/news/url?sa=T&ct=us/0-1&fd=R&url=http://www.businesswire.com/news/google/20081107005060/en&cid=1267865549&ei=CHQ3SeQJhM6AA9aQuIUP&usg=AFQjCNHrKfVtE4Kcm9iQg9qyxfa6fDv88A">Sciele Pharma and Plethora Solutions Announce Positive Phase III <b>...</b></a> <font size=-1 color=#6f6f6f><nobr>Business Wire (press release)</nobr></font></font><br><font size=-1><a href="http://news.google.com/news/url?sa=T&ct=us/0-2&fd=R&url=http://proactiveinvestors.co.uk/companies/news/3378/plethora-reports-positive-outcomes-of-european-phase-iii-trials-of-premature-ejaculation-treatment--3378.html&cid=1267865549&ei=CHQ3SeQJhM6AA9aQuIUP&usg=AFQjCNHL0bBmTW-oPzzVlZkqlp7SB3a_2Q">Plethora: Plethora reports positive outcomes of European Phase III <b>...</b></a> <font size=-1 color=#6f6f6f><nobr>Proactive Investors UK</nobr></font></font><br><font size=-1><a href="http://news.google.com/news/url?sa=T&ct=us/0-3&fd=R&url=http://www.sharecast.com/cgi-bin/sharecast/story.cgi%3Fstory_id%3D2443166&cid=1267865549&ei=CHQ3SeQJhM6AA9aQuIUP&usg=AFQjCNESNcJlQfboN0QSljbcvBL1yVv_NA">Plethora hits target in European trial</a> <font size=-1 color=#6f6f6f><nobr>ShareCast</nobr></font></font><br><font size=-1 class=p><a href="http://news.google.com/news/url?sa=T&ct=us/0-4&fd=R&url=http://www.hemscott.com/news/static/tfn/item.do%3FnewsId%3D70338679474418&cid=1267865549&ei=CHQ3SeQJhM6AA9aQuIUP&usg=AFQjCNGJO-dGzrdPy24kLdzY5vcHNRtD4w"><nobr>Hemscott</nobr></a>&nbsp;- <a href="http://news.google.com/news/url?sa=T&ct=us/0-5&fd=R&url=http://www.growthbusiness.co.uk/news/smallcap-spotlight/812022/eu-trial-cheers-plethora.thtml&cid=1267865549&ei=CHQ3SeQJhM6AA9aQuIUP&usg=AFQjCNFj-rVYaFVaGnmeQ7tNXiiU49CnTA"><nobr>GrowthBusiness.co.uk</nobr></a></font><br/><font class=p size=-1><a class=p href=http://news.google.com/news?ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&tab=wn&ncl=1267865549&hl=en><nobr>all 14 news articles</nobr></a></font></div></font></td></tr></table>]]></content:encoded>
			<wfw:commentRss>http://www.controlyourorgasms.com/wp/135/plethora-premature-ejaculation-drug-meets-goals-reuters-uk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

